Table 1.

Marketed drugs by FDA.

Compound	Date of FDA Authorisation	Natural Source	Clinical Use
Cytarabine	1969	Sponge	Leukaemia
Fludarabine	2004	Sponge	Leukaemia
Trabectedin	2015	Tunicate	Ovarian cancer
Eribulin	2010	Sponge	Breast cancer
Brentuximab vedotin	2011	Mollusk/cyanobacterium	Lymphomas
Lurbinectedin	2020	Tunicate	Ovarian cancer
Polatuzumab vedotin	2019	Mollusk/cyanobacterium	Breast cancer
Enfortumab vedotin	2019	Mollusk/cyanobacterium	Urothelial cancer
Belantamab mafodotin	2020	Mollusk/cyanobacterium	Multiple myeloma